INTRAVITREAL INJECTION OF THERAPEUTIC AGENTS
- 1 July 2009
- journal article
- review article
- Published by Ovid Technologies (Wolters Kluwer Health) in Retina
- Vol. 29 (7), 875-912
- https://doi.org/10.1097/iae.0b013e3181a94f01
Abstract
Intravitreal injection (IVI) with administration of various pharmacological agents is a mainstay of treatment in ophthalmology for endopthalmitis, viral retinitis, age-related macular degeneration, cystoid macular edema, diabetic retinopathy, uveitis, vascular occlusions, and retinal detachment. The indications and therapeutic agents are reviewed in this study. A search of the English, German, and Spanish language MEDLINE database was conducted. A total of 654 references spanning the period through early 2008 were individually evaluated. The advantage of the IVI technique is the ability to maximize intraocular levels of medications and to avoid the toxicities associated with systemic treatment. Intravitreal injection has been used to deliver several types of pharmacological agents into the vitreous cavity: antiinfective and antiinflammatory medications, immunomodulators, anticancer agents, gas, antivascular endothelial growth factor, and several others. The goal of this review is to provide a detailed description of the properties of numerous therapeutic agents that can be delivered through IVI, potential complications of the technique, and recommendations to avoid side effects. The IVI technique is a valuable tool that can be tailored to the disease process of interest based on the pharmacological agent selected. This review provides the reader with a comprehensive summary of the IVI technique and its multitude of uses.Keywords
This publication has 93 references indexed in Scilit:
- Management of Diabetic RetinopathyJAMA, 2007
- Protective effects of intraperitoneal vitamin C, aprotinin and melatonin administration on retinal edema during experimental uveitis in the guinea pigCell Biochemistry and Function, 2004
- VEGF‐TRAPR1R2 suppresses choroidal neovascularization and VEGF‐induced breakdown of the blood–retinal barrierJournal of Cellular Physiology, 2003
- Use of vancomycin in vitrectomy infusion solution and evaluation of retinal toxicityInternational Ophthalmology, 1993
- Assessment of laser‐Induced release of drugs from liposomes: An in vitro studyLasers in Surgery and Medicine, 1990
- Toxicity of intravitreal oxiconazoleInternational Ophthalmology, 1989
- Evaluation of liposome-encapsulated clindamycin inStaphylococcus aureaus endophthalmitisInternational Ophthalmology, 1989
- Resultate mit GlaskörperersatzAlbrecht von Graefes Archiv für Ophthalmologie, 1922
- Über Glaskörperersatz. II. TeilAlbrecht von Graefes Archiv für Ophthalmologie, 1912
- Über die Behandlung der Netzhautablösung durch operative Entleerung der subretinalen Flüssigkeit und Einspritzung von Luft in den GlaskörperAlbrecht von Graefes Archiv für Ophthalmologie, 1911